BOZEN, Sud-Tirol, Italy, May 24, 2010 /PRNewswire/ -- Health Robotics today announced that on the heels of the recently announced Health Robotics-McKesson exclusive partnership [ http://www.pr-inside.com/mckesson-expands-i-v-automation-portfolio-r1873650.h tm] i.v.SOFT and i.v.STATION new product designs and Q&A sessions will be held at the McKesson booth  of the American Society of Health-System Pharmacists' Summer Meeting (ASHP) in Tampa, Florida, June 6-8, 2010.
(Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your Internet browser's URL address field. Remove the space if one exists.)
Despite trailing its competitors by up to 23 years, i.v.STATION is now the fastest growing IV Admixtures Robot in North America, erasing in only 5 months the significant time-to-market lead that Baxa and IHS had in America by expanding IV Robotics to controlled substances, epidurals and other drugs classes, pioneering the first IV Robot in Canada, and with installations already taken place at Allegiance Health, The Brigham & Women's Hospital, Cottage Health System, U Mass Medical Center, and MD Anderson Cancer Center, plus upcoming June/July installations at The Cleveland Clinic Foundation, Centre Hospitalier de l'Universite de Montreal [CHUM], and The University of Colorado-Denver.
"These outstanding results have been made possible by i.v.STATION's cost advantage over IntelliFill -Vial Mode and RIVA [up to 20 times less expensive/per dose], its unparalleled flexibility in syringe and IV Bags brands and sizes [73 different IV containers versus 1 container for IntelliFill and 12 containers for RIVA, respectively], its built-in support for controlled substances [tamper-evident cap, biometric ID, and single slot/drawer access], its small footprint [20 vs. 200 sq. feet], its loading speed [up to 10 times faster], its lower weight (700 vs. 7,000 pounds], its high-availability [up to 99.99%], and its ultra-quick throughput [up to 5 times faster]. With McKesson Automation's technical support in the United States' beginning with our last two installations [MD Anderson and Cottage], we are ready to embark into the next phase of market adoption, showcasing i.v.SOFT and i.v.STATION as prime additions to our I.V. Room of the Future strategy, building upon CytoCare, the first and still only proven robotic solution for chemotherapy, monoclonal antibody therapy, and gene therapy. i.v.SOFT also has significant differences and proven design and 3-to-1 cost advantages over currently available systems, including its cable-less, light-weight, battery-operated and wireless architecture, medical-grade computing, gravimetric control, biometric [facial] identification, and waterproof anti-tampering cameras, all specifically designed for clean-room environments and its specific needs for sterilization, cleaning, wiping, etc." stated Werner Rainer, Health Robotics' CEO.
While most i.v.SOFT competitors' print the IV dose label before compounding even starts [thus delivering a patient label printed before the preparation is actually made and verified], and depend on a Technician's self-documenting audit trail of their work, i.v.SOFT was designed from the ground up to: a) detect compounding errors during the IV preparation phase [as opposed to relying on cursory volumetric review by the IV Room Supervisor]; b) assist Technicians in correcting under and overfilled doses before the IV Admixture leaves the IV Room; and c) print the IV dose label only after the IV dose has been independently verified to be correct via gravimetric control and computer logs. Beta Test/Validation installations of i.v.SOFT Assist, Cube, Label+, and Profile workflow software automation modules will be conducted over the next 2 to 5 months at The Brigham & Women's Hospital in Boston, The Cleveland Clinic Foundation, Duke University Hospital in Durham, Princess Margaret Hospital in Toronto, The University of Chicago Medical Center, and The University of Texas M.D. Anderson Cancer Center in Houston.
About Health Robotics:
Health Robotics is the undisputed global leading supplier of life-critical intra-venous medication robots, providing healthcare facilities in 5 continents with robotics technology and software automation solutions deployed utilizing virtual high-availability technology. Its world-leading solutions CytoCare(TM) [hazardous IVs], i.v.STATION(TM) [non-hazardous IVs], i.v.SOFT(TM) [workflow engine for manual compounding, powered by MEDarchiver], and TPNstation(TM) [totally-automated parenteral nutrition] have and will greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput and contain costs. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' solutions help hospitals eliminate life-threatening drug-exchange errors, decrease other therapy oversights and sterility risks, work more efficiently, reduce waste and controlled substances' diversion, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff.
For more company information including a corporate video, please visit http://www.health-robotics.com/en/about-health-robotics/.For additional information or to schedule a private technical session at the ASHP Summer Meeting in Tampa, please contact: ---------------------------------
 Baxa's IntelliFill was designed in 1993-1995, IHS' RIVA was designed at Winnipeg in 1988-1990.
 No comparison should be made between fully automated IV robots [i.v.STATION and RIVA] with IntelliFill-Reservoir Mode [only partially automated], as "Reservoir" mode is just a syringe filler for manually compounded doses, and as such, subject to contamination and inaccuracies. ---------------------------------
Health Robotics S.r.l. Claudia Flaim Italy: +39-0471-200-372 email@example.com
|SOURCE Health Robotics|
Copyright©2010 PR Newswire.
All rights reserved